Elevated mRNA level of Nrf2 and reduced mRNA level of SLC40A1 were found in three cisplatin–resistant ovarian cancer cells as compared with their corresponding cisplatin-sensitive ovarian cancer cells (Figure 1A). Here, SLC40A1 is linked to ovarian carcinoma.